CORRECTING and REPLACING Cooper & Turner Announces Exclusivity for Potential Combination with Beck Industries
Please replace the release dated June 19, 2019, with the following corrected version due to changes to the headline and first sentence of release.
The corrected release reads:
COOPER & TURNER ANNOUNCES EXCLUSIVITY FOR POTENTIAL COMBINATION WITH BECK INDUSTRIES
Andaray (Holdings) Limited and its direct and indirect subsidiaries (“Cooper & Turner”) have entered into an exclusivity agreement with Beck Industries (“Beck”) for potential combination of the two groups. The contemplated combined entity aims to be the first truly global manufacturer of safety critical fasteners, together supporting a broader range of industries – including renewable energy, tunneling, construction, rail, heavy equipment, downstream oil & gas, power generation and nuclear, among others.
Headquartered in Sheffield, England, Cooper & Turner serves a global customer base with manufacturing and distribution operations across the European Union, China and North America. This worldwide network enables Cooper & Turner to offer a seamless, one-stop shop solution for industrial fasteners that meet the highest levels of quality. Beck, a France-based manufacturer and distributor of fully certified, high-security bolting components, has built a global operation that complements and expands that of Cooper & Turner. The proposed combination of Cooper & Turner and Beck will broaden the geographic reach of both companies, enabling the supply of world-class products and services from 17 strategically positioned facilities throughout Europe, North America, Asia and North Africa.
“It’s an exciting time at Beck,” stated Hugues Charbonnier, President, Beck Industries. “Business is strong, order book is growing, and we have an opportunity with Cooper & Turner to potentially combine our complementary geographic footprint, technologies, and product portfolios to create an unequaled platform to serve our local and international clients.”
“We are energized by the possibility of joining forces with the Beck team to create a new global leader in high quality, mission-critical fasteners,” stated Tony Brown, Group CEO, Cooper & Turner. “Supported by our partners at the Watermill Group, which is a family owned investment company, we see tremendous opportunity to further serve the energy market worldwide.”
The potential combination of Cooper & Turner and Beck is subject to customary conditions, including consultation of the relevant works councils and obtaining required regulatory approvals.
About Cooper & Turner
Founded in the 1800s by Joseph and James Turner as a gun barrel manufacturer, Cooper & Turner is a UK-based manufacturer and distributor of high-strength, large diameter industrial fastener systems. The company serves global organizations in the wind energy, construction, structural bolting, OEM, oil & gas, rail and tunneling industries. Headquartered in Sheffield, England, Cooper & Turner has operations in the United Kingdom, China and the North America.
Beck Industries International Sprl is a European manufacturer and distributor of fully certified, high-security bolting components for refineries, power generation, subsea oil & gas and the nuclear power end markets. Founded in 1918 by Hélène Beck Crespel, the company is now a fourth-generation family business that has grown into an international entity with nine locations in Europe, Asia and North Africa. Learn more at beck-industries.com.
About the Watermill Group
The Watermill Group is a strategy-driven private investment firm that helps companies achieve their full potential through strategic transformation. For more than four decades, the family owned and managed firm has been acquiring, operating and improving companies. Watermill looks for businesses in which it can apply a unique combination of strategic insight and management expertise to re-imagine their future and drive growth.
CXO Communication for Watermill
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alibaba.com Opens Platform to Empower U.S. Small Businesses to Sell to the World23.7.2019 14:30:00 EEST | Press release
Alibaba.com, one of the world’s largest B2B ecommerce marketplaces and a business unit of Alibaba Group (NYSE: BABA), today opened its platform to empower U.S. businesses to sell their products to millions of Alibaba.com buyers in the U.S. and around the globe. Now, the nearly 30 million Small and Medium-sized Businesses (SMBs) in the U.S.– especially manufacturers, wholesalers and distributors – can better access the $23.9 trillion global B2B ecommerce market, an opportunity that is six times larger than the global B2C ecommerce market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190723005345/en/ The company is also unveiling an enhanced ecosystem of participants. These include anchor sellers and B2B service providers who share Alibaba.com’s mission to make it easier for SMBs to do business. To help U.S. SMBs successfully access the $23.9 trillion B2B ecommerce opportunity, Alibaba.com is also co-producing a series of “B
NetMedia Group takes over the management of financial platform Investing.com's European advertising space23.7.2019 11:07:00 EEST | Press release
NetMedia Group, media B2B leader in Europe in the world of business information, and Investing.com, second largest financial services and information platform in Europe, are to form a partnership, with NetMedia Group handling the sales of advertising space for Investing.com. With average traffic of over 21 million unique users totaling over 175 million sessions in 31 countries, Investing.com is one of the top three global financial websites and has the most downloaded financial management app. For Investing.com, the aim of the new partnership is to maximize digital advertising revenue through the NetMedia Group's European teams. NetMedia Group's goal is to expand its advertising services by offering a new vertical market for finance, in order to boost the range of services it has available to decision-makers for upper socio-professional target groups. About NetMedia Group: NetMedia Group is a B2B media group located in five countries across Europe; it employs nearly 150 staff members a
Frost & Sullivan Names Luminati the 2019 Global Market Leader in the Enterprise IP Proxy Networks Market23.7.2019 11:00:00 EEST | Press release
Luminati, the Israeli company that allows businesses to experience the web through the eyes of individual consumers throughout the world, today announced it has received a Market Leadership Award in the first independent analysis of the sector. Luminati’s enterprise IP proxy network (IPPN) services for global retailers, brand owners and advertising networks feature strongly in the report by analyst firm Frost & Sullivan. The report outlines a relatively new, but rapidly growing market and recognizes Luminati’s leading position in the provision of solutions that are increasingly important for businesses to remain competitive and compliant in the digital landscape. [S1] “The market for enterprise IP proxy network solutions is in its early growth stages, basically being invented by Luminati only a few years ago. With the more specialized targeting of customers by demographics and location, companies are finding it more difficult than ever to do competitive analysis and verify advertising,
LifeSpan BioSciences Releases Best-In-Class PathPlus™ Top Performing Immunohistochemistry Antibodies for Cancer Targets23.7.2019 11:00:00 EEST | Press release
LifeSpan BioSciences, Inc. (LSBio™), the industry leader in molecular pathology, today announced the first release of its PathPlus™ series of antibodies. These 565 antibodies were selected from among thousands tested and identified to be the best performing reagents for immunohistochemical detection of 200 high-value cancer targets in formalin-fixed paraffin-embedded human tissues. Antibody validation has become an industry roadblock as thousands of antibodies have become available to customers who face difficult choices in determining which antibodies are the best performers for each application, including immunohistochemistry, flow cytometry, ELISA, Western blot, or immunofluorescence. Antibodies that perform well in one assay, such as IHC, may not be the most specific reagent for another assay, such as flow cytometry. “Identifying the optimal reagents to use in their experiments is a pain point for researchers,” said LSBio CEO Heather Holemon. “There is a tremendous need to identify
IDEMIA Will Present Its H1 2019 Financial Results to Investors on July 30, 201923.7.2019 10:00:00 EEST | Press release
IDEMIA, the world leader in Augmented Identity, today announced that it will present its H1 2019 financial results to investors on Tuesday July 30, 2019. Yann Delabrière (CEO) and Laurent Lemaire (CFO) will be presenting the financial results and taking questions the same day at 3:30 pm CET (2:30 pm London Time / 9:30 am New York Time). For more information, please refer to our website: https://investors.idemia.com/ About IDEMIA IDEMIA, the global leader in Augmented Identity, provides a trusted environment enabling citizens and consumers alike to perform their daily critical activities (such as pay, connect and travel), in the physical as well as digital space. Securing our identity has become mission critical in the world we live in today. By standing for Augmented Identity, an identity that ensures privacy and trust and guarantees secure, authenticated and verifiable transactions, we reinvent the way we think, produce, use and protect one of our greatest assets – our identity – whet
Gain Therapeutics SA Announces Award Notification of a €1.4M Grant Support From Eurostars-2 Together With the Institute for Research in Biomedicine and Neuro-Sys SAS After Having Scored 2nd Among 325 Eligible Applications23.7.2019 09:30:00 EEST | Press release
Gain Therapeutics SA, a biotechnology company discovering and developing novel therapeutics to target lysosomal enzymes involved in inborn errors of metabolism and in central nervous system (CNS) diseases, today announced that together with Dr. Maurizio Molinari from the Institute for Research in Biomedicine, Bellinzona (Switzerland) affiliated to the Università della Svizzera italiana (USI) and Neuro-Sys SAS in Gardanne (France), it has received funding support from Eurostars-2 joint programme with co-funding from the European Union Horizon 2020 research and Innosuisse – Swiss Innovation Agency. This grant will further strengthen Gain Therapeutics’s novel therapeutic approach for targeting rare diseases in the CNS, where lysosomal misfolded enzymes lead to sever clinical phenotypes, where no treatment is available and/or high unmet medical needs still do afflict patients, families and carers. This funding will support the development of the drugs portfolio of Gain Therapeutics for the
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom